Semaglutide/Cyanocobalamin Injectable Syringes Recalled for Lack of Sterility Assurance
Thrive Health Solutions is recalling Semaglutide/Cyanocobalamin Injectable pre-filled syringes due to lack of assurance of sterility. The affected lot was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. The hazard is lack of sterility assurance in an injectable drug product, which presents a direct risk of serious health consequences including infection, even though no illnesses or injuries are reported in the source text.
Plain-English summary
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado), is recalling Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe due to a lack of assurance of sterility. The recalled product consists of 28 syringes from Lot C03075J with an expiration date of 7/7/2025.
The product was distributed nationwide in the United States. Consumers who have received this product should not use it and should contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative treatment option.
The recalled product
- Product
- Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
- Affected units
- 28
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: C03075J
- Ex p 7/7/2025
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
See all →- SevereLX Bioboost Plus Pre-filled Syringe Recalled for Sterility Assurance
FDA (Drugs) · 2025-07-02
- SevereLL Bioboost Injectable pre-filled syringes recalled for lack of sterility assurance
FDA (Drugs) · 2025-07-02
- ModerateTirzepatide Injections Pre-filled Syringe Recalled for Sterility Assurance
FDA (Drugs) · 2025-07-02
- SevereTirzepatide Injections recalled due to lack of sterility assurance
FDA (Drugs) · 2025-07-02
- SevereSemaglutide pre-filled syringe recalled due to sterility concerns
FDA (Drugs) · 2025-07-02
Same hazard · sterility assurance
See all →- SevereSI-BONE iFuse TORQ Implant System Recalled for Sterility Assurance Issues
FDA (Devices) · 2026-10-21
- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
Similar recalls
- HighSemaglutide/Cyanocobalamin Injectable Syringes Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-09-21
- HighSemaglutide/Cyanocobalamin Injectable Syringes Recalled Due to Sterility Failure
FDA (Drugs) · 2022-09-21
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighSemaglutide/Cyanocobalamin Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighCarolina Infusion Semaglutide/Cyanocobalamin Injectable Recalled for Sterility Issue
FDA (Drugs) · 2022-09-21
- SevereCarolina Infusion Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14